Plasma proteomic signatures of dual cognitive and mobility decline in older adultsResearch in context

Summary: Background: The simultaneous memory and gait decline is linked to greater dementia risk than memory decline alone. We aim to identify dual decline-related protein changes that may offer valuable insights into biological processes. Methods: We compared longitudinal changes in 7268 plasma pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Qu Tian, Erin E. Greig, Michael R. Duggan, Keenan A. Walker, Luigi Ferrucci
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:EBioMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396425003020
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839604043003985920
author Qu Tian
Erin E. Greig
Michael R. Duggan
Keenan A. Walker
Luigi Ferrucci
author_facet Qu Tian
Erin E. Greig
Michael R. Duggan
Keenan A. Walker
Luigi Ferrucci
author_sort Qu Tian
collection DOAJ
description Summary: Background: The simultaneous memory and gait decline is linked to greater dementia risk than memory decline alone. We aim to identify dual decline-related protein changes that may offer valuable insights into biological processes. Methods: We compared longitudinal changes in 7268 plasma proteomic markers in older adults experiencing dual decline, memory decline, and gait decline from no decline (reference) using linear mixed-effects regression and related to brain MRI and blood biomarkers. Findings: There were no baseline group differences in proteins. Longitudinally, only dual decline showed significant changes in 75 proteins, with PGP9.5 showing the most alteration (p-FDR < 0.05), implicated in synaptic function, proteostasis, and regulation of amyloid precursor protein and amyloid β protein. The top-enriched pathway pointed to mitochondrial protein degradation. Of 75, changes in select proteins were related to future cognitive impairment, brain atrophy patterns, and blood biomarkers of AD, neuroinflammation, and neurodegeneration, with TRI72 being the top significant protein related to cognitive impairment and pTau181 progression. Interpretation: Older adults experiencing dual decline exhibit longitudinal protein changes, indicating mitochondrial dysfunction, proteostasis, neuroinflammation, and immune responses. Funding: None.
format Article
id doaj-art-db003e972a34453d97c3cda9cff8a00a
institution Matheson Library
issn 2352-3964
language English
publishDate 2025-08-01
publisher Elsevier
record_format Article
series EBioMedicine
spelling doaj-art-db003e972a34453d97c3cda9cff8a00a2025-08-02T04:47:18ZengElsevierEBioMedicine2352-39642025-08-01118105858Plasma proteomic signatures of dual cognitive and mobility decline in older adultsResearch in contextQu Tian0Erin E. Greig1Michael R. Duggan2Keenan A. Walker3Luigi Ferrucci4Longitudinal Studies Section, Translational Gerontology Branch, National Institute on Aging, 251 Bayview Blvd., Suite 100, Baltimore, MD, USA, 21224; Corresponding author. 251 Bayview Blvd., Suite 100, RM 04B332, Baltimore, MD, 21224, USA.Longitudinal Studies Section, Translational Gerontology Branch, National Institute on Aging, 251 Bayview Blvd., Suite 100, Baltimore, MD, USA, 21224Multimodal Imaging of Neurodegenerative Disease Unit, Laboratory of Behavioral Neuroscience, National Institute on Aging, 251 Bayview Blvd., Suite 100, Baltimore, MD, USA, 21224Multimodal Imaging of Neurodegenerative Disease Unit, Laboratory of Behavioral Neuroscience, National Institute on Aging, 251 Bayview Blvd., Suite 100, Baltimore, MD, USA, 21224Longitudinal Studies Section, Translational Gerontology Branch, National Institute on Aging, 251 Bayview Blvd., Suite 100, Baltimore, MD, USA, 21224Summary: Background: The simultaneous memory and gait decline is linked to greater dementia risk than memory decline alone. We aim to identify dual decline-related protein changes that may offer valuable insights into biological processes. Methods: We compared longitudinal changes in 7268 plasma proteomic markers in older adults experiencing dual decline, memory decline, and gait decline from no decline (reference) using linear mixed-effects regression and related to brain MRI and blood biomarkers. Findings: There were no baseline group differences in proteins. Longitudinally, only dual decline showed significant changes in 75 proteins, with PGP9.5 showing the most alteration (p-FDR < 0.05), implicated in synaptic function, proteostasis, and regulation of amyloid precursor protein and amyloid β protein. The top-enriched pathway pointed to mitochondrial protein degradation. Of 75, changes in select proteins were related to future cognitive impairment, brain atrophy patterns, and blood biomarkers of AD, neuroinflammation, and neurodegeneration, with TRI72 being the top significant protein related to cognitive impairment and pTau181 progression. Interpretation: Older adults experiencing dual decline exhibit longitudinal protein changes, indicating mitochondrial dysfunction, proteostasis, neuroinflammation, and immune responses. Funding: None.http://www.sciencedirect.com/science/article/pii/S2352396425003020Plasma biomarkerProteomicsCognitionMobilityAgeingDementia
spellingShingle Qu Tian
Erin E. Greig
Michael R. Duggan
Keenan A. Walker
Luigi Ferrucci
Plasma proteomic signatures of dual cognitive and mobility decline in older adultsResearch in context
EBioMedicine
Plasma biomarker
Proteomics
Cognition
Mobility
Ageing
Dementia
title Plasma proteomic signatures of dual cognitive and mobility decline in older adultsResearch in context
title_full Plasma proteomic signatures of dual cognitive and mobility decline in older adultsResearch in context
title_fullStr Plasma proteomic signatures of dual cognitive and mobility decline in older adultsResearch in context
title_full_unstemmed Plasma proteomic signatures of dual cognitive and mobility decline in older adultsResearch in context
title_short Plasma proteomic signatures of dual cognitive and mobility decline in older adultsResearch in context
title_sort plasma proteomic signatures of dual cognitive and mobility decline in older adultsresearch in context
topic Plasma biomarker
Proteomics
Cognition
Mobility
Ageing
Dementia
url http://www.sciencedirect.com/science/article/pii/S2352396425003020
work_keys_str_mv AT qutian plasmaproteomicsignaturesofdualcognitiveandmobilitydeclineinolderadultsresearchincontext
AT erinegreig plasmaproteomicsignaturesofdualcognitiveandmobilitydeclineinolderadultsresearchincontext
AT michaelrduggan plasmaproteomicsignaturesofdualcognitiveandmobilitydeclineinolderadultsresearchincontext
AT keenanawalker plasmaproteomicsignaturesofdualcognitiveandmobilitydeclineinolderadultsresearchincontext
AT luigiferrucci plasmaproteomicsignaturesofdualcognitiveandmobilitydeclineinolderadultsresearchincontext